|
Proper Name:
dl-Phenylalanine
Common Name:
dl-Phenylalanine/ Phenylalanine
Evidence of Efficacy: statement to the effect of
dl-Phenylalanine deficiency or imbalance plays a role in
the symptoms of mood disorders. Observational and
experimental studies have shown an association between
dl-Phenylalanine and ADHD1,2,3, bipolar
disorder4,5,6,7, and depression7,8,9,10,11,12,13,14,15,16,17.
References:
1.
Bornstein Ra, Baker GB, Carroll A, et al. Plasma amino
acids in attention deficit disorder. Psychiatry Res
33(3):301-6, 1990.
2.
Zametkin AJ et al. Treatment of hyperactive children
with D-phenylalanine. Am J Psychiatry
144(6):792-4, 1987
3.
Wood DR et al. Treatment of attention deficit disorder
with DL-phenylalanine. Psychiatry Res 16:21-6,
1985.
4.Simonson M. L-phenylalanine. Letter. J Clin
Psychiatry 46(8):355, 1985
5.
Sabelli HC et al. Clinical studies on the
phenylethylamine hypothesis of affective disorder: Urine
and blood phenylacetic acid and phenylalanine dietary
supplements. J Clin Psychiatry 47(2):66-70, 1986.
6.
Kravitz HM, Sabelli HC, Fawcett J. Dietary supplements
of phenylalanine and other amino acid precursors of
brain neuroamines in the treatment of depressive
disorders. J Am Osteopath Assoc 84(1) (Suppl):119-23,
1984.
7.
Simonson M. L-phenylalanine. Letter. J Clin
Psychiatry 46(8):355, 1985.
8.
Spatz H, Spatz N. Urinary and brain phenylethylamine
levels under normal and pathological conditions, in AD
Mosnaim & ME Wolf, Eds. Noncatecholic
Phenylethylamines, Part I. New York, Marcel Dekker,
1978:447-74.
9.
Fischer E, Spatz H, Saavedra JM, et al. Urinary
elimination of phenethylamine. Biol Psychiatry
5:139-47, 1972; Mann J, Peselow ED, Snyderm,an S,
Gersohn S. D-phenylalanine in endogenous depression.
Am J Psychiatry 137(12):12, 1980.
10. Beckmann H. Phenylalanine in affective disorders.
Adv Biol Psychiatry 10:137-47, 1983
11. Yaryura-Tobias JA, Neziroglu F. Phenylethylamine and
glucose in true depression. Orthomol Psychiatry
5(3):199-202, 1976.
12. Yaryura-Tobias JA, Heller B, Spatz H, Fischer E.
Phenylalanine for endogenous depression. J Orthomol
Psychiatry 3(2):80-1, 1974.
13. Mann J, Peselow ED, Snyderman S, Gersohon S.
D-phenylalanine in endogenous depression. Am J
Psychiatry 137(12):1611-12, 1980.
14. Braverman ER. The Healing Nutrients Within.
New Canaan CT, Keats Publishing, 1987:37
15. Beckmann H, Athen D, Oheanu M, Zimmer R.
DL-phenylalanine versus imipramine: A double-blind
controlled study. Arch Psychiatr Nervenkr
227:49-58, 1979.
16. Heller B. Pharmacological and clinical effects of
d-phenylalanine in depression and Parkinson’s disease,
in AD Mosnaim & ME Wolf, Eds. Noncatecholic
Phenylethylamines, Part 1. New York, Marcel Dekker,
1978:397-417.
17. Beckmann H, Strauss MA, Ludolph E. DL-phenylalanine
in depressed patients: An open study. J Neural Transm
41(2-3):123-34, 1977.
|